Key points are not available for this paper at this time.
Comorbidities receive little attention in chronic disease trials. Given the public health importance of people with multiple chronic conditions, trials should better report on comorbidities and assess the effect comorbidities have on treatment outcomes.
Boyd et al. (Fri,) studied this question.